Medical Condition News

RSS

Navidea Biopharmaceuticals signs SPA agreements with FDA for NAV5001 Phase 3 program

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that it has reached agreement with the U.S. Food and Drug Administration for two special protocol assessments for the Company's pivotal Phase 3 program with NAV5001 as an aid in the differential diagnosis of Parkinsonian Syndromes from non-Parkinsonian tremor.

23 Aug 2013

Neuroscientist from DZNE wins 1.3M Euros to explore how spatial orientation changes in elderly humans

Prof. Thomas Wolbers from the Magdeburg site of the German Center for Neurodegenerative Diseases (DZNE) has been awarded a "Starting Grant" from the European Research Council (ERC) and thus, the support of one of Europe's most prestigious funding programs. Wolbers, who in 2012 was jointly appointed by the Otto-von-Guericke-Universit-t Magdeburg and the DZNE as professor for "Cognitive Ageing", will explore how spatial orientation changes in elderly humans.

23 Aug 2013

MC1R mutation responsible for red hair phenotype also promotes cancer-causing pathway

A person's skin pigment, which determines hair color and skin tone, is influenced by the melanocortin-1 (MC1R) gene receptor. For the population's one to two percent of redheads, a mutation in MC1R accounts for their red hair color and typical light skin.

23 Aug 2013

Noninvasive urine test can accurately monitor risk of kidney rejection

Levels of a protein in the urine of kidney transplant recipients can distinguish those at low risk of developing kidney injury from those at high risk, a study suggests. The results also suggest that low levels of this protein, called CXCL9, can rule out rejection as a cause of kidney injury.

23 Aug 2013

Brain size can predispose person to develop eating disorders

New research indicates that teens with anorexia nervosa have bigger brains than teens that do not have the eating disorder. That is according to a study by researchers at the University of Colorado's School of Medicine that examined a group of adolescents with anorexia nervosa and a group without.

23 Aug 2013

Scientists identify molecular mechanism that contributes to pancreatic cancer

New research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) and Baylor College of Medicine could aid efforts to diagnose and treat one of the most lethal and hard-to-treat types of cancer.

23 Aug 2013

Aromatherapy, IV dextrose may relieve nausea and vomiting after surgery

Two simple, non-drug treatments-aromatherapy and intravenous administration of a simple sugar solution-may offer effective new approaches to relieving nausea and vomiting after surgery, report a pair of studies in the September issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

22 Aug 2013

Brain Study Suggests New Way To Treat Anxiety

...

22 Aug 2013

Appetite-Controlling Hormone Leaves Obese People Still Hungry

...

22 Aug 2013

Caris Life Sciences to facilitate patient access to tumour profiling service in Middle East and Africa

Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of personalized medicine in oncology, has signed a distribution agreement with IPS Genomix to facilitate patient access to its tumour profiling service, Molecular Intelligence, in select Middle Eastern and African markets.

22 Aug 2013

Nuvo: FDA accepts to review New Drug Application for PENNSAID 2%

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that its U.S. licensee for PENNSAID (diclofenac sodium topical solution) 1.5% w/w and PENNSAID 2% (diclofenac sodium topical solution) 2% w/w, Mallinckrodt has advised that the U.S. Food and Drug Administration has accepted for filing and review the New Drug Application for PENNSAID 2% submitted by Mallinckrodt on August 7, 2013.

22 Aug 2013

Takeda announces publication of data from two vedolizumab Phase 3 studies for ulcerative colitis and Crohn’s disease

Takeda Pharmaceutical Company Limited today announced that results from two Phase 3 studies evaluating vedolizumab, an investigational humanized monoclonal antibody, for the treatment of adults with moderately to severely active ulcerative colitis and Crohn’s disease, were published in the August 22, 2013 issue of the New England Journal of Medicine.

22 Aug 2013

Ireland’s Health Research Board awards €1.2M to UL researchers

University of Limerick researchers have been awarded over €1.2 million funding by Ireland’s Health Research Board. The funding will support health research focused on; primary care reform in Ireland; avoidance of adverse outcomes in vascular surgery; dealing with the progression of chronic kidney disease and enhancing physical activity for multiple sclerosis patients.

22 Aug 2013

Orthopaedic foot and ankle MDs offer foot care tips for diabetics

If you're among the 18 million Americans who've been diagnosed with diabetes, you may know that foot care is extremely important. Nervous system impairment or neuropathy is a major complication of diabetes that can cause you to lose feeling in your feet. This means you may not know right away if you have hurt yourself, which could lead to infection.

22 Aug 2013

Chronic traumatic encephalopathy may affect people's thinking, memory, behavior and mood

New research suggests that chronic traumatic encephalopathy, a brain disease associated with repeat brain trauma including concussions in athletes, may affect people in two major ways: initially affecting behavior or mood or initially affecting memory and thinking abilities.

22 Aug 2013

Use of psychotherapy on a clear decline in US

Psychotherapy has issues. Evidence shows that some psychosocial treatments work well for common mental health problems such as anxiety and depression and that consumers often prefer them to medication.

22 Aug 2013

Journal of Spinal Cord Medicine's July issue focuses on assistive technology for spinal cord injury

The July issue of the Journal of Spinal Cord Medicine focuses on, "Advances in Technology for People with Spinal Cord Injury." Guest Editor Rory Cooper, PhD, is a member of the journal's Editorial Board. Dr. Cooper is the FISA/PVA Endowed Chair and a Distinguished Professor of the Department of Rehabilitation Science and Technology, School of Health and Rehabilitation Sciences, University of Pittsburgh.

22 Aug 2013

Research findings may lead to treatments for disorders triggered by circadian clock dysfunction

Overnight flights across the Atlantic, graveyard shifts, stress-induced insomnia are all prime culprits in keeping us from getting a good night's sleep. Thanks to new research from McGill University and Concordia University, however, these common sleep disturbances may one day be put to bed.

22 Aug 2013

Antipsychotic drug not effective in treating delirium in critically ill patients

Haloperidol, an antipsychotic drug used in many hospitals to treat delirium in critically ill patients, is no more effective than placebo in reducing the number of days that critically ill patients spend either delirious or in a coma, according to new research published in The Lancet Respiratory Medicine.

22 Aug 2013

Clinical study to investigate effects of prenatal chromosomal abnormalities through microarray analysis

Reproductive genetics researchers at Columbia University Medical Center (CUMC) are leading a multicenter prospective clinical study investigating the effects of chromosomal abnormalities (duplicative or missing material) found prenatally through microarray analysis.

22 Aug 2013

Medical Condition News

Navidea Biopharmaceuticals signs SPA agreements with FDA for NAV5001 Phase 3 program

Neuroscientist from DZNE wins 1.3M Euros to explore how spatial orientation changes in elderly humans

MC1R mutation responsible for red hair phenotype also promotes cancer-causing pathway

Noninvasive urine test can accurately monitor risk of kidney rejection

Brain size can predispose person to develop eating disorders

Scientists identify molecular mechanism that contributes to pancreatic cancer

Aromatherapy, IV dextrose may relieve nausea and vomiting after surgery

Brain Study Suggests New Way To Treat Anxiety

Appetite-Controlling Hormone Leaves Obese People Still Hungry

Caris Life Sciences to facilitate patient access to tumour profiling service in Middle East and Africa

Nuvo: FDA accepts to review New Drug Application for PENNSAID 2%

Takeda announces publication of data from two vedolizumab Phase 3 studies for ulcerative colitis and Crohn’s disease

Ireland’s Health Research Board awards €1.2M to UL researchers

Orthopaedic foot and ankle MDs offer foot care tips for diabetics

Chronic traumatic encephalopathy may affect people's thinking, memory, behavior and mood

Use of psychotherapy on a clear decline in US

Journal of Spinal Cord Medicine's July issue focuses on assistive technology for spinal cord injury

Research findings may lead to treatments for disorders triggered by circadian clock dysfunction

Antipsychotic drug not effective in treating delirium in critically ill patients

Clinical study to investigate effects of prenatal chromosomal abnormalities through microarray analysis

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News